Resveratrol as a therapeutic agent for neurodegenerative diseases.
Sun
Albert Y
AY
Department of Medical Pharmacology and Physiology, University of Missouri, Columbia, MO 65212, USA. suna@health.missouri.edu
Wang
Qun
Q
Simonyi
Agnes
A
Sun
Grace Y
GY
D020268:Alcohol-Induced Disorders, Nervous System / Q000188:drug therapy; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D016923:Cell Death / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D009457:Neuroglia / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress / Q000187:drug effects; D026361:Reactive Nitrogen Species / Q000009:adverse effects / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000009:adverse effects / Q000378:metabolism; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology / Q000627:therapeutic use*; D020521:Stroke / Q000188:drug therapy
D000975:Antioxidants; D026361:Reactive Nitrogen Species; D017382:Reactive Oxygen Species; D013267:Stilbenes; D000077185:Resveratrol